DelveInsight's analysis indicates a promising outlook for the dry eye disease market from 2024 to 2034, with positive growth anticipated. This growth trajectory is attributed to the emergence ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Forte Biosciences (FBRX – Research Report) and ...

Minister Lokesh seeks Indian Ambassador's cooperation to set up pharma companies in Andhra Pradesh, highlighting investment ...

AR-17043 is under clinical development by Alcon and currently in Phase II for Ocular Hypertension ... to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence ...

The main portion of employees (over 60,000) worked in pharmaceuticals – the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating ...

The global ophthalmic sprays market, valued at USD 343 million in 2023, is projected to experience exponential growth, reaching a remarkable USD 783.3 million by 2033. This growth is underpinned by a ...